Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies
Abstract Background Chemotherapy for schistosomiasis has been around for 100 years. During the past century, great efforts have been made to develop new antischistosomal drugs from antimonials to nonantimonials, and some of these have been used extensively in clinical treatment. With the exception o...
Main Authors: | Shu-Hua Xiao, Jun Sun, Ming-Gang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Infectious Diseases of Poverty |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40249-018-0391-x |
Similar Items
-
In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
by: Xiaoli Wang, et al.
Published: (2019-05-01) -
Mini-review: the ultrasonographical and serological chanbges and their improvement after praziquantel treatment Schistosoma japonicum infected patients in Leyete, Philippines
by: Manami Tanaka
Published: (1992-01-01) -
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
by: Emily L. Webb, et al.
Published: (2021-09-01) -
In vivo efficiency of praziquantel treatment of single-sex Schistosoma japonicum aged three months old in mice
by: Ning Wang, et al.
Published: (2022-12-01) -
Altered Response of Strain of Schistosoma mansoni to Oxamniquine and Praziquantel
by: Patrícia Ivana Pires Bonesso-Sabadini, et al.
Published: (2002-04-01)